Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 19, 2026 02:00 ET | Source: Khondrion B.V.

Khondrion Announces First Patient Dosed in Phase II Study Targeting Debilitating Post-COVID Fatigue

Khondrion announced that the first patient has been dosed in the Phase II SON4PEM study evaluating sonlicromanol in Post-COVID.